The global genotyping market, valued at USD 15.1 billion in 2022, is projected to reach an impressive USD 44.9 billion by 2030. This represents a robust compound annual growth rate (CAGR) of 14.6% over the forecast period from 2023 to 2030. The market's expansion is driven by technological advancements, increasing applications in personalized medicine, and the lingering impacts of the...